Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
In the Literature
In the Literature - April 2017
In the Literature
April 2017, Vol 8, No 2
Read Article
In the Literature - November 2016
In the Literature
November 2016, Vol 7, No 10
Read Article
In the Literature - October 2016
In the Literature
October 2016, Vol 7, No 9
Read Article
In the Literature - September 2016
In the Literature
September 2016, Vol 7, No 8
Read Article
In the Literature - August 2016
In the Literature
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Read Article
In the Literature - July 2016
In the Literature
July 2016, Vol 7, No 6
Read Article
In the Literature - June 2016
In the Literature
June 2016, Vol 7, No 5
Read Article
In the Literature - May 2016
In the Literature
May 2016, Vol 7, No 4
The oncology National Practice Benchmark (NPB) annual report provides important information regarding oncology providers’ productivity, costs, practice revenues, and profits. Key findings from the 2015 report show that new patient visits and average drug spending are on the rise (Balch C, et al. J Oncol Pract. 2016;12:e437-e475).
Read Article
In the Literature - April 2016
In the Literature
April 2016, Vol 7, No 3
Read Article
In the Literature - March 2016
In the Literature
March 2016, Vol 7, No 2
Read Article
Page 3 of 13
1
2
3
4
5
6
7
8
9
10
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma